MEDICAMEN BIOTECH
|
The Current P/E Ratio of MEDICAMEN BIOTECH is 57.49.
| Share Price | ₹359.5 | Jan 21,2026 |
| Market Cap | ₹488.9 Cr | |
| Earnings-TTM | ₹8.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 57.49x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of MEDICAMEN BIOTECH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹488.9 Cr] as on Jan 21,2026
(/) Earnings [ ₹8.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 57.49x ]
Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay 57.49 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MEDICAMEN BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MEDICAMEN BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of MEDICAMEN BIOTECH
PE Ratio Performance Analysis for MEDICAMEN BIOTECH
- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 61.52x.
- MEDICAMEN BIOTECH 's operated at median p/e ratio of 53.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2025 at 93.43x.
- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2024 of 51.31x.
How does MEDICAMEN BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| MEDICAMEN BIOTECH | 8.50 | 57.49 | 488.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 36.79 | 386,905.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 64.13 | 159,357.0 |
| CIPLA LTD | 5,453.86 | 20.28 | 110,628.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 62.99 | 134,788.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 17.51 | 96,441.5 |
| MANKIND PHARMA LTD | 1,767.06 | 49.05 | 86,682.9 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 17.73 | 88,156.2 |
| LUPIN LTD | 4,347.53 | 22.48 | 97,727.5 |
| AUROBINDO PHARMA LTD | 3,447.75 | 18.90 | 65,145.6 |
| ABBOTT INDIA LTD | 1,508.95 | 38.87 | 58,658.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MEDICAMEN BIOTECH 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.51x |
| Max industry PE | 64.13x |
| Median industry PE | 36.79x |
| Average industry PE | 36.93x |
You may also like the below Video Courses